...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: TD Waterhouse-TFSA

Just for myself, I'd want to see the eligibility of ZEN shares written in the TFSA rules.  And I sure don't see it.  Significant penalties for getting it wrong....

 

 

Share
New Message
Please login to post a reply